European Survey of Non-Variceal Upper Gastro Intestinal Bleeding (NVUGIB) - ENERGIB
Study identifier:NIS-GEU-DUM-2008/2
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
European Survey of Non-Variceal Upper Gastro Intestinal Bleeding
Medical condition
Non-variceal upper gastrointestinal bleeding
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
2500
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Jan 2009
Primary Completion Date: 01 Feb 2009
Study Completion Date: 01 Mar 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Patients admitted to the hospital, or inpatients admitted for another reason, presenting with overt non-variceal upper GI bleed manifesting as hematemesis/coffee ground vomiting, melena, hematochezia, as well as other clinical or laboratory evidence of acute blood loss from the upper gastrointestinal tract | - |
Contacts
Investigators
Principal Investigator
Ángel Lanas
Hospital Clínico Universitario Lozano Blesa, Zaragoza (Spain)
